| ASSETS |
| Cash and equivalents |
19.77M |
| Short-term investments |
1.29M |
| Accounts receivable |
477.18K |
| Other current assets |
1.14M |
| Total current assets |
22.67M |
| EQUIPMENT |
| Computer equipment |
| Lab equipment |
| Furniture |
| Property, Plant and Equipment, Gross, Total |
| Less accumulated depreciation |
| Property, Plant and Equipment, Net, Total |
910.9K |
| OTHER ASSETS |
| Intellectual property |
| Other long term assets |
61.59K |
| Deposits |
| Assets Noncurrent excluding Property, Plant and Equipment |
| TOTAL ASSETS |
25.18M |
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
| Accounts payable |
1.23M |
| Deferred revenue |
3.02M |
| Accrued expenses |
3.29M |
| Accrued bonuses |
| Accrued warrant liability |
7.55M |
| Total current liabilities |
15.17M |
| LONG TERM LIABILITIES |
| Deferred revenue |
| Total long term liabilities |
| Commitments and contingencies - See Note 9 |
| STOCKHOLDERS' EQUITY (DEFICIT) |
| Common stock, $.005 par value Authorized - 80,000,000 shares at June 30, 2011 and December 31, 2010 Issued and outstanding 35,373,096 and 28,959,176 shares at June 30, 2011 and December 31, 2010, respectively |
224.56K |
| Additional paid-in capital |
124.26M |
| Accumulated other comprehensive income (loss) |
454.28K |
| Accumulated deficit |
-128.07M |
| Total Cleveland BioLabs, Inc. stockholders' equity (deficit) |
-3.13M |
| Noncontrolling Interest in stockholders' equity |
13.06M |
| Total stockholders' equity (deficit) |
9.93M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
25.18M |
